Antibiotic switch after treatment with UTI antibiotics in male patients

References

• World Health Organization. Antimicrobial resistance: global report on surveillance. Geneva: World Health Organization; 2014.
   Google Scholar
• NORM/NORM-VET 2018. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromsø/Oslo: NORM/NORM-VET; 2019. ISSN:15002-2307 (print)/1890-9965 (electronic).
   Google Scholar
• Straand J, Rokstad KS, Sandvik H. Prescribing systemic antibiotics in general practice. A report from the Møre & Romsdal prescription study. Scand J Prim Health Care. 1998;16(2):121–127.
   PubMed Web of Science ®Google Scholar
• Griebling TL. Urologic diseases in America project: trends in resource use for urinary tract infections in men. J Urol. 2005;173(4):1288–1294.
   PubMed Web of Science ®Google Scholar
• Lipsky BA. Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med. 1989;110(2):138–150.
   PubMed Web of Science ®Google Scholar
• Caljouw MAA, den Elzen WPJ, Cools HJM, et al. Predictive factors of urinary tract infections among the oldest old in the general population. A population-based prospective follow-up study. BMC Med. 2011;9(1):57–57.
   PubMedGoogle Scholar
• Ahmed H, Farewell D, Jones HM, et al. Incidence and antibiotic prescribing for clinically diagnosed urinary tract infection in older adults in UK primary care, 2004–2014. PLoS One. 2018;13(1):e0190521.
   PubMed Web of Science ®Google Scholar
• Gupta K, Grigoryan L, Trautner B. Urinary tract infection. Ann Intern Med. 2017;167(7):ITC49–ITC64.
   PubMed Web of Science ®Google Scholar
• Naber KG, Bergman B, Bishop MC, et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol. 2001;40(5):576–588.
   PubMed Web of Science ®Google Scholar
• Wagenlehner FH, Fünfstück R, et al. Epidemiology, diagnostics, therapy and management of uncomplicated bacterial community acquired urinary tract infections in adults S3 Guideline Urinary Tract Infections Urologenportal. 2010. AWMF-Register-Nr. 043/044.
   Google Scholar
• Ulleryd P, Sandberg T. Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up. Scand J Infect Dis. 2003;35(1):34–39.
   PubMed Web of Science ®Google Scholar
• van Nieuwkoop C, van der Starre WE, Stalenhoef JE, et al. Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women. BMC Med. 2017;15(1):70.
   PubMedGoogle Scholar
• Trautner BW. New perspectives on urinary tract infection in men comment on “urinary tract infection in male veterans: treatment patterns and outcomes” and on “preoperative urine cultures at a veterans affairs medical center. JAMA Intern Med. 2013;173(1):68–70.
   PubMed Web of Science ®Google Scholar
• Germanos GJ, Trautner BW, Zoorob RJ, et al. No clinical benefit to treating male urinary tract infection longer than seven days: an outpatient database study. Open Forum Infect Dis. 2019;6(6):ofz216.
   PubMed Web of Science ®Google Scholar
• Drekonja DM, Rector TS, Cutting A, et al. Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med. 2013;173(1):62–68.
   PubMed Web of Science ®Google Scholar
• Mospan GA, Wargo KA. 5-Day versus 10-day course of fluoroquinolones in outpatient males with a urinary tract infection (UTI). J Am Board Fam Med. 2016;29(6):654–662.
   PubMed Web of Science ®Google Scholar
• Boel JB, Jansåker F, Hertz FB, et al. Treatment duration of pivmecillinam in men, non-pregnant and pregnant women for community-acquired urinary tract infections caused by Escherichia coli: a retrospective Danish cohort study. J Antimicrob Chemother. 2019;74(9):2767–2773.
   PubMed Web of Science ®Google Scholar
• Ingalsbe ML, Wojciechowski AL, Smith KA, et al. Effectiveness and safety of nitrofurantoin in outpatient male veterans. Ther Adv Urol. 2015;7(4):186–193.
   PubMed Web of Science ®Google Scholar
• Helsedirektoratet. Anitbiotikabruk i primaerhelsetjenesten. Nasjonal faglig retningslinje for antibiotikabruk i primaerhelsetjenesten. 2012.
   Google Scholar
• The Norwegian Institute of Public Health. The Norwegian Prescription Database 2019. Vol 2019. Available from: http://www.norpd.no.
   Google Scholar
• WHO Collaborating Centre for Drug Statistics Methology, Guidelines for ATC classification and DDD assignment 2019. Oslo, Norway, 2018.
   Google Scholar
• Statistics Norway 2019. Population, by sex, age, contents and year. Available from: http://www.ssb.no/en/statbank/table/07459.
   Google Scholar
• Rowe TA, Juthani-Mehta M. Diagnosis and management of urinary tract infection in older adults. Infect Dis Clin North Am. 2014;28(1):75–89.
   PubMed Web of Science ®Google Scholar
• Appaneal HJ, Caffrey AR, Lopes VV, et al. National trends in the treatment of urinary tract infections among Veterans’ Affairs Community Living Center residents. Infect Control Hosp Epidemiol. 2019;40(10):1087–1093.
   PubMed Web of Science ®Google Scholar
• Aypak C, Altunsoy A, Düzgün N. Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study. Ann Clin Microbiol Antimicrob. 2009;8(1):27.
   PubMedGoogle Scholar
• Tandan M, Cormican M, Vellinga A. Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: a systematic review and meta-analysis of randomized controlled trials. Int J Antimicrob Agents. 2018;52(5):529–540.
   PubMed Web of Science ®Google Scholar
• Bjerrum L, Dessau RB, Hallas J. Treatment failures after antibiotic therapy of uncomplicated urinary tract infections. A prescription database study. Scand J Prim Health Care. 2002;20(2):97–101.
   PubMed Web of Science ®Google Scholar
• Lawrenson RA, Logie JW. Antibiotic failure in the treatment of urinary tract infections in young women. J Antimicrob Chemother. 2001;48(6):895–901.
   PubMed Web of Science ®Google Scholar
• Tandan M, Duane S, Cormican M, et al. Reconsultation and antimicrobial treatment of urinary tract infection in male and female patients in general practice. Antibiotics (Basel, Switzerland). 2016;5(3):31.
   Web of Science ®Google Scholar
• Goettsch WG, Janknegt R, Herings R. Increased treatment failure after 3-days’ courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database. Br J Clin Pharmacol. 2004;58(2):184–189.
   PubMed Web of Science ®Google Scholar
• Blandhol M, Tysland T, Blix HS, et al. Antibiotic switch during treatment with antibiotics against respiratory tract infections in ambulatory care in Norway. Infect Dis (London, England). 2017;49(11–12):854–858.
   PubMed Web of Science ®Google Scholar
• Currie CJ, Berni E, Jenkins-Jones S, et al. Antibiotic treatment failure in four common infections in UK primary care 1991–2012: longitudinal analysis. Br Med J. 2014;349(3):g5493–g5493.
   PubMed Web of Science ®Google Scholar
• Montelin H, Forsman K-J, Tängdén T. Retrospective evaluation of nitrofurantoin and pivmecillinam for the treatment of lower urinary tract infections in men. PloS One. 2019;14(1):e0211098.
   PubMed Web of Science ®Google Scholar
• Ulleryd P. Febrile urinary tract infection in men. Int J Antimicrob Agents. 2003;22:89–93.
   PubMed Web of Science ®Google Scholar
• Peterson LR. Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance. Clin Microbiol Infect. 2005;11(Suppl 5):4–16.
   PubMedGoogle Scholar